PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Laboratory Medicine and Pathology, School of Medicine, University of Minnesota, Minneapolis MN, USA.\', \'Department of Microbiology and Immunology, Center for Immunology, School of Medicine, University of Minnesota, Minneapolis, MN, USA.\', \'Department of Medicine, Division of Rheumatology, Center for Immunology, School of Medicine, University of Minnesota, Minneapolis, MN, USA.\', \'M Health Fairview University of Minnesota Medical Center West Bank Laboratory, Minneapolis, MN, USA.\', \'Department of Medicine, Division of Infectious Diseases and International Medicine, School of Medicine, University of Minnesota, Minneapolis, MN, USA.\', \'Department of Laboratory Medicine and Pathology, School of Medicine, University of Minnesota, Minneapolis MN, USA. Electronic address: karge026@umn.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0009-9120(21)00027-810.1016/j.clinbiochem.2021.01.010
?:hasPublicationType
?:journal
  • Clinical biochemistry
is ?:pmid of
?:pmid
?:pmid
  • 33539808
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.984
?:rankingScore_hIndex
  • 95
?:title
  • Initial determination of COVID-19 seroprevalence among outpatients and healthcare workers in Minnesota using a novel SARS-CoV-2 total antibody ELISA.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all